BNT323/DB-1303 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: trastuzumab pamirtecan

Filter by location:

Washington D.C., District of Columbia1 trial

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

MedStar Washington Hospital Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.